Literature DB >> 17721877

The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section.

Sergio E Starkstein1, Marcelo Merello.   

Abstract

The objective of this study was to examine the validity of the mentation, behavior, and mood items included in Part I of the Unified Parkinson's Disease Rating Scale (UPDRS) and to assess its usefulness to screen for dementia, psychosis, depression, and apathy. A consecutive series of 168 patients with PD were assessed by neurologists with the UPDRS, and by psychiatrists using a comprehensive neuropsychiatric evaluation blind to each other's ratings. ROC analysis demonstrated that a score of 2 or greater on the intellectual impairment item of the UPDRS had 60% sensitivity and 92% specificity to detect dementia, as diagnosed with DSM-IV criteria. When a score of 23 or lower on the MMSE was included as an additional classification variable, the sensitivity increased to 85%. A score of 2 or greater on the thought disorder item had 43% sensitivity and 92% specificity to detect psychotic symptoms (delusions or hallucinations). A score of 2 or greater on the depression item had 77% sensitivity and 82% specificity to detect major depression as diagnosed with DSM-IV criteria. Finally, a score of 2 or greater on the motivation/initiative item had 73% sensitivity and 65% specificity to detect apathy, as diagnosed with a standardized criteria. When the sample was divided into mild (i.e. Hohen-Yahr stages I and II) versus moderate-severe PD (i.e. Hohen-Yahr stages III-V), findings remained unchanged, except that the UPDRS show unacceptably low accuracy to detect psychosis in mild PD. The mentation, behavior, and mood section of the UPDRS is an adequate screen for depression and apathy, and has adequate sensitivity to detect dementia when combined with the Mini-Mental State Exam, but has low sensitivity to detect psychosis. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17721877     DOI: 10.1002/mds.21521

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

Review 2.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

Review 3.  Detecting depression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Zahra Goodarzi; Kelly J Mrklas; Derek J Roberts; Nathalie Jette; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

4.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

5.  A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

Authors:  J R Williams; E S Hirsch; K Anderson; A L Bush; S R Goldstein; S Grill; S Lehmann; J T Little; R L Margolis; J Palanci; G Pontone; H Weiss; P Rabins; L Marsh
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

6.  Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Authors:  E Y Uc; M P McDermott; K S Marder; S W Anderson; I Litvan; P G Como; P Auinger; K L Chou; J C Growdon
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

7.  Computerized assessment of goal-directed behavior in Parkinson's disease.

Authors:  Whitney Fitts; Lauren Massimo; Nicholas Lim; Murray Grossman; Nabila Dahodwala
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

8.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

9.  How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale?

Authors:  Lindsey Kirsch-Darrow; Laura B Zahodne; Chris Hass; Ania Mikos; Michael S Okun; Hubert H Fernandez; Dawn Bowers
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

10.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Authors:  S Hoops; S Nazem; A D Siderowf; J E Duda; S X Xie; M B Stern; D Weintraub
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.